Davis Polk & Wardwell is advising Roche on the transaction, and Freshfields Bruckhaus Deringer is advising Roivant.Roivant (Nasdaq: ROIV) announced it has entered into a definitive agreement…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
